NEW YORK, NY / ACCESSWIRE / April 5, 2024 /Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Shockwave Medical, Inc. ("Shockwave" or the "Company") (NASDAQ:SWAV), in connection with its acquisition by Johnson & Johnson (NYSE: JNJ). Under the merger agreement, the Company's shareholders will receive $335.00per share. The transaction is valued at approximately $13.1 billion.

If you own Shockwave shares and wish to discuss this investigation or have any questions concerning this notice or your rights or interests, visit our website:

https://www.weisslaw.co/news-and-cases/swav

Or please contact:

Joshua Rubin, Esq.Weiss Law 305 Broadway, 7th FloorNew York, NY 10007(212) 682-3025(888) 593-4771stockinfo@weisslawllp.com

Weiss Law is investigating whether (i) the Shockwave board acted in the best interests of Company shareholders in agreeing to the merger, (ii) the merger consideration adequately compensates Shockwave shareholders, and (iii) all information regarding the sales process and valuation of the transaction will be fully and fairly disclosed. Notably, at least one analyst set a price target for the Company of $361per share, $26.00 above the merger price.

Weiss Law has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties. We have recovered over a billion dollars for defrauded clients and obtained important corporate governance relief in many of these cases. If you have information or would like legal advice concerning possible corporate wrongdoing (including insider trading, waste of corporate assets, accounting fraud, or materially misleading information), consumer fraud (including false advertising, defective products, or other deceptive business practices), or anti-trust violations, please email us at stockinfo@weisslawllp.com

SOURCE: Weiss Law

COMTEX_450390014/2457/2024-04-05T15:46:18